<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04905394</url>
  </required_header>
  <id_info>
    <org_study_id>SubCond</org_study_id>
    <nct_id>NCT04905394</nct_id>
  </id_info>
  <brief_title>Clinical and Radiological Outcomes of Subchondroplasty in the Treatment of Bone Marrow Edema of the Knee</brief_title>
  <official_title>Short Term Clinical and Radiological Outcomes of Subchondroplasty in the Treatment of Bone Marrow Edema of the Knee</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Milan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Milan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bone marrow lesions (BMLs) of the knee are common subchondral defects, often associated with&#xD;
      pain and functional limitation. Subchondroplasty is a percutaneous procedure in which calcium&#xD;
      phosphate is injected inside BML areas, ensuring stability and promoting the deposition of&#xD;
      new bone. Primary outcome of this study was to obtain a reduction of the Numeric Rating Scale&#xD;
      score of 4 points or more at 6 months follow-up in more than 75% of patients. The secondary&#xD;
      outcome was to evaluate the osteoarthritic and bone marrow structure evolution in the months&#xD;
      after the procedure.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Actual">January 30, 2021</completion_date>
  <primary_completion_date type="Actual">January 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain reduction</measure>
    <time_frame>6 months</time_frame>
    <description>Pain reduction of 4 points in numeric rating score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiological evaluation</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluation of osteoarthritis progression in the knee on x-rays according to Kellgren&amp;Lawrence classification</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Bone Marrow Edema</condition>
  <arm_group>
    <arm_group_label>Treatment with subchondroplasty for bone edema in the knee</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients treated with subchondroplasty for bone edema of the knee</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>subchondroplasty</intervention_name>
    <description>subchondroplasty is an innovative percutaneous procedure in which calcium phosphate, biocompatible material similar to the native bone apatite with osteoinductive properties, is injected inside BML areas. The purpose of subchondroplasty is the patient's symptoms relief, improving the mechanical strength of subchondral bone, stimulating bone remodeling to avoid bone sagging, and slow down the arthritic degenerative process to postpone arthroplasty.</description>
    <arm_group_label>Treatment with subchondroplasty for bone edema in the knee</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Atraumatic knee pain for at least 3 months;&#xD;
&#xD;
          -  Failure of conservative treatment (including NSAIDs, physical therapy, intra-&#xD;
             articular injection with steroids or hyaluronic acid and bisphosphonates);&#xD;
&#xD;
          -  Mild to moderate osteoarthritis (Kellgren-Lawrence18 grade â‰¤ 3)&#xD;
&#xD;
          -  BML on a loading area at MRI imaging (femoral condyles and/or tibial plateau)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Knee pain and functional limitation related to other causes like osteonecrosis&#xD;
&#xD;
          -  Fractures or inflammatory arthritis&#xD;
&#xD;
          -  Ligamentous instabilities&#xD;
&#xD;
          -  Malalignment on the coronal axis greater than 10 degrees in varus/valgus&#xD;
&#xD;
          -  Severe tri-compartmental arthritis (Kellgren-Lawrence grade 4)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>pietro randelli, prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Milan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gaetano Pini hospital</name>
      <address>
        <city>Milano</city>
        <state>Lombardy</state>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 18, 2021</study_first_submitted>
  <study_first_submitted_qc>May 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 27, 2021</study_first_posted>
  <last_update_submitted>May 26, 2021</last_update_submitted>
  <last_update_submitted_qc>May 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Milan</investigator_affiliation>
    <investigator_full_name>Pietro Randelli, MD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Edema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Researcher will not share data with other organizations</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

